ZA934740B - Treatment of inflammatory bowel disease - Google Patents

Treatment of inflammatory bowel disease

Info

Publication number
ZA934740B
ZA934740B ZA934740A ZA934740A ZA934740B ZA 934740 B ZA934740 B ZA 934740B ZA 934740 A ZA934740 A ZA 934740A ZA 934740 A ZA934740 A ZA 934740A ZA 934740 B ZA934740 B ZA 934740B
Authority
ZA
South Africa
Prior art keywords
inflammatory bowel
bowel disease
treatment
disease
carboxypyrazoles
Prior art date
Application number
ZA934740A
Other languages
English (en)
Inventor
David Russell Blake
Jill Ann Panetta
Nicola Jane Simmonds
Peter Peck-Koh Ho
David Stephen Rampton
Original Assignee
Lilly Co Eli
London Hospital Med Coll
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, London Hospital Med Coll filed Critical Lilly Co Eli
Publication of ZA934740B publication Critical patent/ZA934740B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA934740A 1992-07-07 1993-07-01 Treatment of inflammatory bowel disease ZA934740B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/909,852 US5294630A (en) 1992-07-07 1992-07-07 Treatment of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
ZA934740B true ZA934740B (en) 1995-01-03

Family

ID=25427924

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA934740A ZA934740B (en) 1992-07-07 1993-07-01 Treatment of inflammatory bowel disease

Country Status (11)

Country Link
US (1) US5294630A (de)
EP (1) EP0578477B1 (de)
JP (1) JPH06157310A (de)
AT (1) ATE139440T1 (de)
AU (1) AU672977B2 (de)
CA (1) CA2099789A1 (de)
DE (1) DE69303234T2 (de)
DK (1) DK0578477T3 (de)
ES (1) ES2090875T3 (de)
GR (1) GR3021114T3 (de)
ZA (1) ZA934740B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10168095A (ja) 1996-12-10 1998-06-23 Cci Corp 炎症性腸疾患予防および治療剤
US6485938B1 (en) * 1999-11-16 2002-11-26 Zymogenetics, Inc. Nucleic acid molecules that encodes human Zven1
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US20030118329A1 (en) * 2001-12-21 2003-06-26 Pere Obrador Video indexing using high resolution still images
EP1558287A4 (de) * 2002-10-07 2009-07-08 Zymogenetics Inc Verwendungen von humanen zven-antagonisten
WO2005072113A2 (en) 2004-01-20 2005-08-11 Harty Richard F Compositions and methods of treatment for inflammatory diseases
US20080219985A1 (en) * 2005-09-13 2008-09-11 Thompson Penny J Prok2 antagonists and methods of use
ES2276618B1 (es) * 2005-12-02 2008-06-16 Laboratorios Casen-Fleet, S.L. Utilizacion rectal de una solucion de cloruro de sodio.
JP5199884B2 (ja) * 2006-12-06 2013-05-15 カルピス株式会社 炎症性腸疾患予防治療剤
WO2010042933A2 (en) 2008-10-10 2010-04-15 Northwestern University Inhibition and treatment of prostate cancer metastasis
US9839625B2 (en) 2014-11-06 2017-12-12 Northwestern University Inhibition of cancer cell motility

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544752A (en) * 1980-09-22 1985-10-01 Eli Lilly And Company 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels
US4346094A (en) * 1980-09-22 1982-08-24 Eli Lilly And Company 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels
US4495195A (en) * 1982-11-01 1985-01-22 Eli Lilly And Company Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use
WO1992009279A1 (en) * 1990-11-30 1992-06-11 Teijin Limited 2-arylthiazole derivative and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
DE69303234T2 (de) 1996-11-21
AU4175893A (en) 1994-01-13
JPH06157310A (ja) 1994-06-03
US5294630A (en) 1994-03-15
GR3021114T3 (en) 1996-12-31
CA2099789A1 (en) 1994-01-08
ATE139440T1 (de) 1996-07-15
DK0578477T3 (da) 1996-07-15
EP0578477B1 (de) 1996-06-19
DE69303234D1 (de) 1996-07-25
EP0578477A1 (de) 1994-01-12
ES2090875T3 (es) 1996-10-16
AU672977B2 (en) 1996-10-24

Similar Documents

Publication Publication Date Title
TW249226B (de)
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
NL300174I2 (nl) Toepassing van venlafaxine of een aryloxypropaanamineverbinding voor de bereiding van een geneesmiddel voor de behandeling van incontinentie.
GR3023537T3 (en) Inhibition of thrombin.
MX9205981A (es) Administracion transdermica de melatonina.
GR3021114T3 (en) Treatment of inflammatory bowel disease.
ATE150307T1 (de) Hemmung von seborrhoe und akne
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
ATE128459T1 (de) Sulfonanilidderivat und arzneimittel.
NO307689B1 (no) Anvendelse av et antimikrobielt middel
ATE125704T1 (de) Behandlung neurodegenerativer erkrankungen.
EP0328924A3 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische Anwendungen
EP0644765A4 (de) Bindemittel enthaltende metallpulverzusammensetzungen für hochtemperaturverdichtung.
ZA931063B (en) Treatment of glaucoma.
ATE88634T1 (de) Arzneimittel zur behandlung von herzinsuffizienz.
AU1494395A (en) The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
FR2691064B3 (fr) Nouveau medicament pour le traitement de l'arythmie.
ATE223212T1 (de) Conagenine zur prävention und behandlung von diarrhöe
FI933872A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4h)-on-derivat
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
FR2692261B1 (fr) Procédé de préparation d'un télogène actif.
FR2693194B1 (fr) Dérivés d'alcanecarboxamide, leur préparation et leur application thérapeutique.
GB9201764D0 (en) The use of a compound for the manufacture of a medicament for the treatment of hiv infection
NO950842L (no) Diarylpiperazinoacetamidforbindelser som antimuskariniske midler